
Anti-tumor effects of a 'human & mouse cross-reactive' anti-ADAM17 antibody in a pancreatic cancer model in vivo
Keywords: Pancreatic ductal adenocarcinoma (PDAC); ADAM17; Inhibitory antibody; Tumorigenesis; Targeted therapy;